The approval of the first malaria treatment for newborns and young infants could lead to imminent widespread use in Africa, ...

Coartem® (artemether-lumefantrine) Baby becomes first malaria treatment approved for newborn babies and young infants Rapid approvals in eight African countries now expected under a special global ...

The newly approved medication, Coartem Baby, is a combination of two antimalarials. It is a lower dose version of a tablet ...

Novartis has received approval in Switzerland for Coartem Baby, the first drug designed specifically to treat malaria in ...

Novartis has received approval for Coartem Baby, the world's first malaria treatment specifically for newborns and young ...

Novartis said on Tuesday it had received approval in Switzerland for Coartem Baby, which it said was the first drug to treat ...

A sweet cherry flavour, including in breast milk, and easily dissovleable drug is now approved for the treatment of malaria ...

The new drug, developed by Novartis and MMV, isn't a malaria vaccine, but can help treat babies with the disease.

The first malaria treatment suitable for babies and very young children has been approved for use.It's expected to be rolled ...

The medicine, called Coartem Baby (also known as Riamet Baby), was approved by Switzerland’s health agency, Swissmedic.

Novartis' Coartem Baby wins Swiss approval as the first malaria drug for newborns under 5 kg, offering safer dosing and ...